… in cough medicines since 1979 has shown promise as a treatment for … gold-standard phase 2 clinical trial, 22 participants with Parkinson… Canada. "This early trial offers hope and provides a … GCase activity. In the current trial, those taking the drug …

… report chest pain, chronic cough, loss of appetite, shortness … symptoms. Sunvozertinib is a treatment that has molecular structure … oral reception.1 The medication is an irreversible EGFR … receives-fda-accelerated-approval-as-the-only-targeted-oral-treatment- …

… 12-month clinical trial investigating the cough medicine Ambroxol and … offers a promising new treatment avenue where few currently … will go on to develop disease-related dementia within … investigating Ambroxol for the treatment of motor neurone disease …

Parkinson’s disease dementia develops in people who have a Parkinson’s disease diagnosis. Experts are interested in finding the best ways to address and prevent Parkinson’s disease dementia. A randomized clinical trial found that the drug Ambroxol may help …

… investigating whether Ambroxol - a cough medicine used safely for decades … Neurology, this 12-month clinical trial involving 55 participants with Parkinson … is an important step toward developing new treatments for Parkinson’s disease …

… baseline and week 12 Leicester Cough Questionnaire scores, researchers further observed … patents, publications, grants and clinical trial databases to further assess the … it so challenging to develop innovative drugs and treatments for IPF? The main …

… with no safe, affordable treatments to slow its progression. … whether Ambroxol -- a cough medicine used safely for … this 12-month clinical trial involving 55 participants with Parkinson … an important step toward developing new treatments for Parkinson's …

… remedies. Anecdotally, I have found that my hacking cough … Of note, while steam treatment helps to relieve congestion … when you start to develop symptoms the antiviral effects … research, including controlled clinical trials and standardized protocols, to …

In a groundbreaking development poised to transform respiratory healthcare, … smartphones to record exhalation and cough sounds, subsequently analyzing these … progression, predict exacerbations, or evaluate treatment efficacy. With continuous advancements in …

… in the LINKER-MM1 trial. Continued approval for this … could help reduce treatment burden.” The FDA approval is based … advancing our broad clinical development program for Lynozyfic – … prescribed Lynozyfic access their medication. The company has launched …